Correlation Between Aquestive Therapeutics and 67077MAN8

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and 67077MAN8 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and 67077MAN8 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and NUTRIEN LTD 4125, you can compare the effects of market volatilities on Aquestive Therapeutics and 67077MAN8 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of 67077MAN8. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and 67077MAN8.

Diversification Opportunities for Aquestive Therapeutics and 67077MAN8

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aquestive and 67077MAN8 is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and NUTRIEN LTD 4125 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NUTRIEN LTD 4125 and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with 67077MAN8. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NUTRIEN LTD 4125 has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and 67077MAN8 go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and 67077MAN8

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 18.72 times less return on investment than 67077MAN8. But when comparing it to its historical volatility, Aquestive Therapeutics is 19.14 times less risky than 67077MAN8. It trades about 0.09 of its potential returns per unit of risk. NUTRIEN LTD 4125 is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  8,847  in NUTRIEN LTD 4125 on August 24, 2024 and sell it today you would earn a total of  109.00  from holding NUTRIEN LTD 4125 or generate 1.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy42.94%
ValuesDaily Returns

Aquestive Therapeutics  vs.  NUTRIEN LTD 4125

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Aquestive Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
NUTRIEN LTD 4125 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NUTRIEN LTD 4125 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for NUTRIEN LTD 4125 investors.

Aquestive Therapeutics and 67077MAN8 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and 67077MAN8

The main advantage of trading using opposite Aquestive Therapeutics and 67077MAN8 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, 67077MAN8 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 67077MAN8 will offset losses from the drop in 67077MAN8's long position.
The idea behind Aquestive Therapeutics and NUTRIEN LTD 4125 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments